Pharmacokinetics and Metabolism of Natural Methylxanthines in Animal and Man (Q34139392)

1

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives

17 July 2024

2

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Caffeine disposition in obesity

17 July 2024

3

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

17 July 2024

4

7

378

A Aldridge

1979

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Relationship between the clearance of caffeine and its 7-N-demethylation in developing beagle puppies

17 July 2024

5

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Theophylline pharmacokinetics and liver function indexes in chronic liver disease

17 July 2024

7

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Metabolism of Theophylline to Caffeine in Human Fetal Liver

17 July 2024

9

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Dose-dependency in the exsorption of theophylline and the intestinal dialysis of theophylline by oral activated charcoal in rats

17 July 2024

10

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Identification, kinetic and quantitative study of [2-14C] and [1-Me-14C]caffeine metabolites in rat's urine by chromatographic separations

17 July 2024

11

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

17 July 2024

15

13

471

MJ Arnaud

1985

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques

17 July 2024

16

31

273

MJ Arnaud

1987

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Research Communications in Chemical Pathology and Pharmacology

17 July 2024

21

52

407

MJ Arnaud

1986

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Placental transfer of the major caffeine metabolite in the rat using 6-amino-5[N-formylmethylamino]1,3[Me-14C]-dimethyluracil administered orally or intravenously to the pregnant rat.

17 July 2024

24

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Metabolism and distribution of labeled theophylline in the pregnant rat. Impairment of theophylline metabolism by pregnancy and absence of a blood-brain barrier in the fetus.

17 July 2024

25

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Study of the demethylation of [1,3,7-Me-13C] caffeine in man using respiratory exchange measurements

17 July 2024

30

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Metabolic pathway of theobromine in the rat and identification of two new metabolites in human urine

17 July 2024

31

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract

17 July 2024

37

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Evaluation of the central effects of alcohol and caffeine interaction

17 July 2024

38

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Rofecoxib is a potent inhibitor of cytochrome P450 1A2: studies with tizanidine and caffeine in healthy subjects

17 July 2024

39

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Artemisinin and thiabendazole are potent inhibitors of cytochrome P450 1A2 (CYP1A2) activity in humans

17 July 2024

40

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

A study on the route of 1-methylurate formation in theophylline metabolism

17 July 2024

41

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Differences in pharmacokinetic and electroencephalographic responses to caffeine in sleep-sensitive and non-sensitive subjects

17 July 2024

42

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

The bronchodilator effects and pharmacokinetics of caffeine in asthma

17 July 2024

44

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

In vivo evaluation of CYP1A2, CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios

17 July 2024

45

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Sympathomimetic effects of paraxanthine and caffeine in humans

17 July 2024

46

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Total theophylline clearance in childhood: the influence of age-dependent changes in metabolism and elimination

17 July 2024

47

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

17 July 2024

48

18

327

T Bienvenu

1990

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Secondary metabolism of theophylline biotransformation products in man--route of formation of 1-methyluric acid

17 July 2024

49

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

17 July 2024

50

13

725

DJ Birkett

1985

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Caffeine renal clearance and urine caffeine concentrations during steady state dosing. Implications for monitoring caffeine intake during sports events

17 July 2024

51

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Effect of diet on the development of drug metabolism by cytochrome P-450 enzymes in healthy infants

17 July 2024

52

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

The absolute bioavailability of caffeine in man

17 July 2024

53

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Comparative pharmacokinetics of caffeine in young and elderly men

17 July 2024

54

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Relationship between urine flow rate and renal clearance of caffeine in man

17 July 2024

55

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Comparison of the urinary metabolite profile of caffeine in young and elderly males

17 July 2024

56

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Relationship between serum and saliva theophylline levels in patients with cystic fibrosis

17 July 2024

57

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Caffeine disposition after oral doses

17 July 2024

59

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Kinetics and metabolism of theobromine in male rats

17 July 2024

60

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

17 July 2024

61

13

227

A Bortolotti

1985

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Metabolism of theophylline to caffeine in premature newborn infants

17 July 2024

62

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Methylation of theophylline to caffeine in premature infants

17 July 2024

63

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

American Journal of Physiology

17 July 2024

64

269

E671

D Bracco

1995

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Research Communications in Chemical Pathology and Pharmacology

17 July 2024

66

53

269

Y Brandstetter

1986

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Inhibition by idrocilamide of the disposition of caffeine

17 July 2024

67

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Study of theophylline metabolism in premature human newborns using stable isotope labelling

17 July 2024

68

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Fluvoxamine is a potent inhibitor of cytochrome P4501A2

17 July 2024

69

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Determination of intraluminal theophylline concentrations after oral intake of an immediate- and a slow-release dosage form.

17 July 2024

70

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Caffeine and cigarette smoking: behavioral, cardiovascular, and metabolic interactions

17 July 2024

71

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Changes in rate and pattern of caffeine metabolism after cigarette abstinence

17 July 2024

72

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

17 July 2024

Pathology and Biology

73

35

181

B Bruguerolle

1987

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites.

17 July 2024

74

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

17 July 2024

75

10

417

MM Callahan

1982

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

17 July 2024

76

15

237

ME Campbell

1987

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

A urinary metabolite ratio that reflects systemic caffeine clearance

17 July 2024

77

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

International journal of obesity

17 July 2024

78

19

234

Y Caraco

1995

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Evaluation of caffeine as an in vivo probe for CYP1A2 using measurements in plasma, saliva, and urine

17 July 2024

79

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Effect of sodium tanshinone II A sulfonate on the activity of CYP1A2 in healthy volunteers.

17 July 2024

80

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Simultaneous action of the flavonoid quercetin on cytochrome P450 (CYP) 1A2, CYP2A6, N-acetyltransferase and xanthine oxidase activity in healthy volunteers.

17 July 2024

81

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Dose-dependent pharmacokinetics of caffeine in humans: relevance as a test of quantitative liver function

17 July 2024

82

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

The Karolinska cocktail for phenotyping of five human cytochrome P450 enzymes.

17 July 2024

83

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Effect of age and smoking on in vivo CYP1A2, flavin-containing monooxygenase, and xanthine oxidase activities in Koreans: determination by caffeine metabolism

17 July 2024

84

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Effects of moderate exercise on the pharmacokinetics of caffeine

17 July 2024

86

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Transcutaneous chemical collection of caffeine in normal subjects: relationship to area under the plasma concentration-time curve and sweat production

17 July 2024

87

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

17 July 2024

Theophylline toxicity

88

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Pharmacokinetic and pharmacodynamic interactions between zolpidem and caffeine

17 July 2024

91

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

17 July 2024

92

24

1058

TJ Danielson

1996

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Interaction profile of armodafinil with medications metabolized by cytochrome P450 enzymes 1A2, 3A4 and 2C19 in healthy subjects

17 July 2024

93

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Caffeine demethylation monitoring using a transdermal sweat patch

17 July 2024

95

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Dose-dependency of caffeine metabolism with repeated dosing

17 July 2024

96

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Nicotine metabolism in three ethnic/racial groups with different risks of lung cancer

17 July 2024

97

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Theophylline pharmacokinetics: comparison of Cyp1a1(-/-) and Cyp1a2(-/-) knockout mice, humanized hCYP1A1_1A2 knock-in mice lacking either the mouse Cyp1a1 or Cyp1a2 gene, and Cyp1(+/+) wild-type mice.

17 July 2024

98

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Impaired elimination of caffeine in cirrhosis

17 July 2024

99

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Maternal caffeine consumption and fetal behavior in normal third-trimester pregnancy

17 July 2024

100

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Induction of CYP1A2 by heavy coffee consumption in Serbs and Swedes

17 July 2024

101

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Caffeine and paraxanthine pharmacokinetics in the rabbit: concentration and product inhibition effects

17 July 2024

102

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Maturational changes of theophylline pharmacokinetics in preterm infants

17 July 2024

104

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

CYP1A2 activity is an important determinant of clozapine dosage in schizophrenic patients

17 July 2024

105

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Two novel methods for the determination of CYP1A2 activity using the paraxanthine/caffeine ratio

17 July 2024

106

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Evaluation of theophylline pharmacokinetics in a pediatric population using mixed effects models

17 July 2024

107

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Studies on theobromine disposition in normal subjects; Alterations induced by dietary abstention from or exposure to methylxanthines

17 July 2024

108

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

The pharmacokinetics of theophylline in premature neonates during the first few days after birth

17 July 2024

109

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Time response of cytochrome P450 1A2 activity on cessation of heavy smoking

17 July 2024

111

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Dose-dependency of theophylline clearance and protein binding

17 July 2024

112

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Caffeine based measures of CYP1A2 activity correlate with oral clearance of tacrine in patients with Alzheimer's disease

17 July 2024

113

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity in vivo and in vitro

17 July 2024

114

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man.

17 July 2024

115

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the "cocktail" approach

17 July 2024

117

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Theophylline disposition in obesity

17 July 2024

118

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Effects of tobacco smoking and oral contraceptive use on theophylline disposition

17 July 2024

120

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Longitudinal effects of pregnancy on the pharmacokinetics of theophylline

17 July 2024

121

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Cytochrome P450 isoform selectivity in human hepatic theobromine metabolism

17 July 2024

122

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Influence of alcohol and caffeine consumption on caffeine elimination

17 July 2024

123

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans

17 July 2024

124

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

The fate of chronically consumed caffeine in the monkey (Macaca fascicularis).

17 July 2024

125

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Urinary metabolites of caffeine in the premature infant

17 July 2024

126

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Changes in theophylline metabolism during postnatal development in rat liver slices

17 July 2024

127

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism

17 July 2024

128

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2.

17 July 2024

129

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Polymorphic N-acetylation of a caffeine metabolite

17 July 2024

130

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

A simple test for acetylator phenotype using caffeine

17 July 2024

131

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Effect of allopurinol on caffeine disposition in man.

17 July 2024

132

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

The relationship between phenazone (antipyrine) metabolite formation and theophylline metabolism in healthy and frail elderly women

17 July 2024

133

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Caffeine metabolism, genetics, and perinatal outcomes: a review of exposure assessment considerations during pregnancy

17 July 2024

134

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Prenatal caffeine assessment: fetal and maternal biomarkers or self-reported intake?

17 July 2024

135

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Effect of age on patterns of theophylline metabolism

17 July 2024

136

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Cigarette smoking and theophyiiine clearance and metabolism

17 July 2024

137

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1

17 July 2024

138

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans

17 July 2024

139

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Metabolism of theophylline by cDNA-expressed human cytochromes P-450.

17 July 2024

140

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Biotransformation of caffeine by cDNA-expressed human cytochromes P-450.

17 July 2024

141

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use.

17 July 2024

142

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Effects of malnutrition on cytochrome P450 1A2 activity in elderly patients

17 July 2024

143

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Diurnal Effect on Caffeine Clearance

17 July 2024

144

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

American journal of hospital pharmacy

17 July 2024

145

34

525

L Hendeles

1977

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Correlation of caffeine elimination and Child's classification in liver cirrhosis

17 July 2024

147

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Effect of gender on theophylline clearance in the asthmatic acute phase in Japanese pediatric patients

17 July 2024

148

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Distribution studies of theophylline: microdialysis in rat and horse and whole body autoradiography in rat

17 July 2024

149

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

The relationship between theophylline clearance and age in adult life

17 July 2024

150

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Toxicokinetics of caffeine elimination in an infant

17 July 2024

151

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

A fluvoxamine-caffeine interaction study

17 July 2024

153

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Serum metabolite/caffeine ratios as a test for liver function

17 July 2024

154

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Food reduces the rate but not the extent of the absorption of theophylline from an aqueous solution

17 July 2024

155

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

The influence of caffeine on the steady-state pharmacokinetics of theophylline.

17 July 2024

156

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

The effects of age and dietary protein restriction on the pharmacokinetics of theophylline in the rat.

17 July 2024

157

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Influence of Cigarette Smoking on Drug Metabolism in Man

17 July 2024

158

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Factors affecting theophylline clearances: Age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol

17 July 2024

159

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Progress in Clinical and Biological Research

17 July 2024

160

340B

107

FF Kadlubar

1990

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Dietary effect on mixed function P450 1A2 activity assayed by estimation of caffeine metabolism in man.

17 July 2024

161

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Progress in Clinical and Biological Research

17 July 2024

162

214

331

W Kalow

1986

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities

17 July 2024

163

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Caffeine as a metabolic probe: exploration of the enzyme-inducing effect of cigarette smoking

17 July 2024

164

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

The effects of obesity and exercise on the pharmacokinetics of caffeine in lean and obese volunteers

17 July 2024

166

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Human N-acetylation genotype determination with urinary caffeine metabolites

17 July 2024

170

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Pharmacokinetics of theophylline in diabetes mellitus rats: induction of CYP1A2 and CYP2E1 on 1,3-dimethyluric acid formation

17 July 2024

171

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Blood flow changes and conceptal development in pregnant rats in response to caffeine

17 July 2024

172

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Cyp2a6 is a principal enzyme involved in hydroxylation of 1,7-dimethylxanthine, a main caffeine metabolite, in humans

17 July 2024

173

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2

17 July 2024

174

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Metabolism of caffeine and theophylline in rats with malaria and endotoxin-induced fever

17 July 2024

175

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

The use of theophylline clearance in pediatric status asthmaticus. I. Interpatient and intrapatient theophylline clearance variability

17 July 2024

176

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Theophylline metabolism in healthy nonsmokers and in patients with insulin-dependent diabetes mellitus

17 July 2024

177

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

The caffeine CO2 breath test: dose response and route of N-demethylation in smokers and nonsmokers

17 July 2024

178

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Alterations in theophylline metabolism during the first year of life

17 July 2024

179

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Nonlinear renal excretion of theophylline and its metabolites, 1-methyluric acid and 1,3-dimethyluric acid, in rats.

17 July 2024

180

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Differences in caffeine and paraxanthine metabolism between human and murine CYP1A2.

17 July 2024

181

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

IARC scientific publications

17 July 2024

182

148

173

MT Landi

1999

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Menstrual cycle effects on caffeine elimination in the human female

17 July 2024

183

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Urinary excretion of an uracilic metabolite from caffeine by rat, monkey and man.

17 July 2024

185

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Kinetics and metabolism of theobromine in male and female non-pregnant and pregnant rabbits

17 July 2024

186

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Oral and IP caffeine pharmacokinetics under a chronic food-limitation condition

17 July 2024

187

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Theophylline population pharmacokinetics from routine monitoring data in very premature infants with apnoea

17 July 2024

189

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man.

17 July 2024

190

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Quantitative assessment of caffeine partial clearances in man.

17 July 2024

191

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Mechanism of formation of 6-amino-5-(N-methylformylamino)-1-methyluracil and 3,7-dimethyluric acid from theobromine in the rat in vitro: involvement of cytochrome P-450 and a cellular thiol

17 July 2024

193

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Potential interactions between exercise and drug therapy

17 July 2024

194

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Theophylline serum protein binding in obstructive airways disease

17 July 2024

195

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Theophylline toxicokinetics in premature newborns

17 July 2024

198

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

A novel pathway for the metabolism of caffeine by a mixed culture consortium

17 July 2024

199

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Evaluation of the influence of diabetes mellitus on antipyrine metabolism and CYP1A2 and CYP2D6 activity

17 July 2024

200

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Effects of exercise and thermal stress on caffeine pharmacokinetics in men and eumenorrheic women

17 July 2024

201

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Theophylline metabolism by human, rabbit and rat liver microsomes and by purified forms of cytochrome P450

17 July 2024

202

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

17 July 2024

203

20

302

PJ McNamara

1992

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

17 July 2024

204

12

154

GE Miller

1984

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

17 July 2024

205

10

672

JO Miners

1982

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

17 July 2024

206

13

598

JO Miners

1985

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Influence of methylxanthine-containing foods on theophylline metabolism and kinetics

17 July 2024

207

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

The effect of increased caffeine intake on the metabolism and pharmacokinetics of theophylline in man

17 July 2024

208

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

The population pharmacokinetics of theophylline in neonates and young infants

17 July 2024

209

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Archives francaises de pediatrie

17 July 2024

210

47

221

C Morisot

1990

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Placental passage of benzoic acid, caffeine, and glyphosate in an ex vivo human perfusion system

17 July 2024

211

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Absorption rate of methylxanthines following capsules, cola and chocolate.

17 July 2024

212

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

The effect of smoking on caffeine elimination: implications for its use as a semiquantitative test of liver function

17 July 2024

213

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Absorption of theophylline from the small and large intestine of the neonatal piglet

17 July 2024

214

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Comparison of CYP1A2 and NAT2 phenotypes between black and white smokers

17 July 2024

215

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Use of quantitative liver function tests--caffeine clearance and galactose elimination capacity--after orthotopic liver transplantation

17 July 2024

216

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

The effect of caffeine ingestion on pharmacokinetics of caffeine and its metabolites after a single administration in pregnant rats.

17 July 2024

217

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Effect of hepatic cirrhosis on the pharmacokinetics of theophylline in rats

17 July 2024

218

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Plasma and salivary pharmacokinetics of caffeine in man

17 July 2024

219

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma

17 July 2024

220

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Clinical Pharmacokinetics of Theophylline

17 July 2024

221

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Effects of caffeine on tobacco withdrawal

17 July 2024

222

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Placental transfer of theophylline during in situ perfusion in the rabbit

17 July 2024

223

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population

17 July 2024

224

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Lack of a pharmacokinetic interaction between lansoprazole or pantoprazole and theophylline

17 July 2024

225

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Biotransformation of theophylline in cirrhotic rats induced by biliary obstruction

17 July 2024

226

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Validity of the 13C-caffeine breath test as a noninvasive, quantitative test of liver function

17 July 2024

227

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

High-performance liquid chromatographic separation of caffeine, theophylline, theobromine and paraxanthine in rat brain and serum

17 July 2024

228

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Effect of smoking on caffeine clearance

17 July 2024

229

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Effect of pH on theophylline transfer across the everted rat jejunum

17 July 2024

231

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Maturation of caffeine N-demethylation in infancy: a study using the 13CO2 breath test

17 July 2024

232

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

The American Review of Respiratory Disease

17 July 2024

233

116

17

JR Powell

1977

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors

17 July 2024

234

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Caffeine: a model compound for measuring liver function

17 July 2024

235

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Breast milk distribution of theobromine from chocolate

17 July 2024

236

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Rapid onset of an increase in caffeine residence time in young women due to oral contraceptive steroids

17 July 2024

237

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Characterisation of theophylline metabolism by human liver microsomes. Inhibition and immunochemical studies

17 July 2024

238

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

The effects of quinolones on xanthine pharmacokinetics

17 July 2024

239

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Assessment of dimethylxanthine formation from caffeine in healthy adults: comparison between plasma and saliva concentrations and urinary excretion of metabolites

17 July 2024

240

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Elimination of theobromine metabolites in healthy adults

17 July 2024

241

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Elimination of theophylline metabolites in healthy adults

17 July 2024

242

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation

17 July 2024

243

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Accelerated caffeine metabolism after omeprazole treatment is indicated by urinary metabolite ratios: coincidence with plasma clearance and breath test

17 July 2024

244

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Development of the "Inje cocktail" for high-throughput evaluation of five human cytochrome P450 isoforms in vivo

17 July 2024

245

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Increases in cerebrospinal fluid caffeine concentration are associated with favorable outcome after severe traumatic brain injury in humans

17 July 2024

246

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Ueber Paraxanthin und Heteroxanthin

17 July 2024

247

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

17 July 2024

248

20

31

MA Sarkar

1992

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

17 July 2024

249

22

827

MA Sarkar

1994

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

A population phenotyping study of three drug-metabolizing enzymes in Kyushu, Japan, with use of the caffeine test

17 July 2024

250

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Influence of usual intake of dietary caffeine on single-dose kinetics of theophylline in healthy human subjects

17 July 2024

251

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Pharmacokinetics of theophylline in Guinea pig tears.

17 July 2024

252

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Caffeine demethylation measured by breath analysis in experimental liver injury in the rat

17 July 2024

253

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Effect of exercise and environmental heat on theophylline kinetics

17 July 2024

254

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

17 July 2024

Biochemical Pharmacology

256

5

1155

D Schrenk

1998

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Determination of caffeine, theophylline and theobromine in serum and saliva using high-performance liquid chromatography

17 July 2024

257

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Urinary metabolites of caffeine in pregnant women

17 July 2024

258

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Caffeine clearance and biotransformation in patients with chronic liver disease

17 July 2024

259

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

The pharmacokinetics of caffeine and its dimethylxanthine metabolites in patients with chronic liver disease

17 July 2024

260

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Factors influencing theophylline serum protein binding

17 July 2024

261

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Theobromine metabolism and pharmacokinetics in pregnant and nonpregnant Sprague-Dawley rats

17 July 2024

263

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

High levels of methylxanthines in chocolate do not alter theobromine disposition

17 July 2024

265

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Comparison of unbound and total serum theophylline concentrations with those of stimulated and unstimulated saliva in asthmatic children

17 July 2024

266

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Validation of different microdialysis methods for the determination of unbound steady-state concentrations of theophylline in blood and brain tissue

17 July 2024

268

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Toxic Interaction Between Fluvoxamine and Sustained Release Theophylline in an 11-Year-Old Boy

17 July 2024

270

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Lack of correlation between fluvoxamine clearance and CYP1A2 activity as measured by systemic caffeine clearance

17 July 2024

272

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Drug distribution studies with microdialysis: I. Tissue dependent difference in recovery between caffeine and theophylline

17 July 2024

273

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Drug distribution studies with microdialysis. II. Caffeine and theophylline in blood, brain and other tissues in rats

17 July 2024

274

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Serum caffeine half-lives. Healthy subjects vs. patients having alcoholic hepatic disease

17 July 2024

275

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Discordance between N-acetyltransferase 2 phenotype and genotype in a population of Hmong subjects

17 July 2024

276

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".

17 July 2024

277

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Phenotype-genotype analysis of CYP1A2 in Japanese patients receiving oral theophylline therapy

17 July 2024

278

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Simplified approach for evaluation of hepatic drug-oxidizing capacity with a simultaneous measurement of caffeine and its primary demethylated metabolites in carbon tetrachloride-intoxicated rats

17 July 2024

279

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

International journal of clinical pharmacology, therapy, and toxicology

17 July 2024

280

30

336

E Tanaka

1992

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Comparison of hepatic drug-oxidizing activity after simultaneous administration of two probe drugs, caffeine and trimethadione, to human subjects

17 July 2024

281

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Changes in the metabolism of three model substrates catalysed by different P450 isozymes when administered as a cocktail to the carbon tetrachloride-intoxicated rat.

17 July 2024

282

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

17 July 2024

283

11

218

BK Tang

1983

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Research Communications in Chemical Pathology and Pharmacology

17 July 2024

286

34

371

DD Tang-Liu

1981

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

The toxicology of cocoa and methylxanthines: a review of the literature

17 July 2024

288

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Theobromine kinetics and metabolic disposition

17 July 2024

289

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A2, 2E1 and 3A isoforms

17 July 2024

290

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Influence of oral contraceptives on drug therapy

17 July 2024

291

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Dose-dependent elimination of theophylline in rats

17 July 2024

292

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Effect of chronic oral contraceptive steroids on theophylline disposition

17 July 2024

293

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Relationship between total body clearance of caffeine and urine flow rate in elderly men

17 July 2024

294

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

17 July 2024

296

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Developmental aspects of theophylline metabolism in premature infants.

17 July 2024

297

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

The effect of pregnancy on cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activities in humans

17 July 2024

298

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Pharmacokinetic interactions between theophylline and other medication (Part I).

17 July 2024

300

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Caffeine-induced hyperactivity in the horse: comparisons of drug and metabolite concentrations in blood and cerebrospinal fluid

17 July 2024

301

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Cytochrome P450 IA2 activity in man measured by caffeine metabolism: effect of smoking, broccoli and exercise

17 July 2024

302

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Foreign compound metabolism capacity in man measured from metabolites of dietary caffeine

17 July 2024

303

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Uncertainty factors for chemical risk assessment: interspecies differences in the in vivo pharmacokinetics and metabolism of human CYP1A2 substrates

17 July 2024

304

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Caffeine pharmacokinetics in young and adult dogs

17 July 2024

305

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

17 July 2024

306

10

424

D Warszawski

1982

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Dose-dependent kinetics of theophylline disposition in asthmatic children

17 July 2024

307

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Assessment of the cytochrome P-448 dependent liver enzyme system by a caffeine breath test

17 July 2024

308

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

The effect of multiple-dose oral lomefloxacin on theophylline metabolism in man

17 July 2024

309

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Accumulation of theophylline, theobromine and paraxanthine in the fetal rat brain following a single oral dose of caffeine.

17 July 2024

310

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Occurrence of selected pharmaceuticals in an agricultural landscape, western Lake Erie basin.

17 July 2024

311

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Induction of cytochrome P450 1A by cow milk-based formula: a comparative study between human milk and formula

17 July 2024

312

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Effects of CYP inducers and inhibitors on the pharmacokinetics of intravenous theophylline in rats: involvement of CYP1A1/2 in the formation of 1,3-DMU.

17 July 2024

313

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Population pharmacokinetics of theophylline. I: Intravenous infusion to children in the acute episode of asthma

17 July 2024

314

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Progress in Clinical and Biological Research

17 July 2024

315

158

215

DW Yesair

1984

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Population pharmacokinetics of caffeine and its metabolites theobromine, paraxanthine and theophylline after inhalation in combination with diacetylmorphine

17 July 2024

316

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Drug interactions with tobacco smoking. An update

17 July 2024

317

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Characterization of human cytochromes P450 involved in theophylline 8-hydroxylation

17 July 2024

318

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Assessment of cytochrome P450 activity by a five-drug cocktail approach

17 July 2024

319

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3

Pharmacokinetics of caffeine in patients with decompensated type I and type II diabetes mellitus

17 July 2024

320

1 reference

https://api.crossref.org/works/10.1007/978-3-642-13443-2_3